Automated, efficient and model-free inference for randomized clinical trials via data-driven covariate adjustment

Fuente: arXiv
Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Van Lancker, Kelly, Díaz, Iván, Vansteelandt, Stijn
Format: Preprint
Veröffentlicht: 2024
Schlagworte:
Online-Zugang:
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
_version_ 1866917538972041216
author Van Lancker, Kelly
Díaz, Iván
Vansteelandt, Stijn
author_facet Van Lancker, Kelly
Díaz, Iván
Vansteelandt, Stijn
contents In 2023, the U.S. Food and Drug Administration issued guidance for adjustment of covariates in randomized clinical trials, emphasizing its role in enhancing precision and power through prognostic baseline variables. Despite its potential, many trials underutilize this method partly due to challenges in pre-specifying optimal baseline covariates and their functional forms. We explore the potential of automated, data-adaptive methods-including stepwise regression, Lasso and flexible machine learning algorithms-for covariate adjustment, addressing the challenge of pre-specification. Our approach ensures valid and interpretable treatment effect estimates and standard errors, even when outcome models are misspecified or biased outcome predictions are used. This differs from most competing methods, which assume correctly specified models for consistent standard errors. Our estimators require cross-fitting for reliable standard error estimation, though it can be omitted when variable selection is used, provided the outcome model satisfies an ultra-sparsity assumption. As such, we arrive at simple estimators and standard errors for marginal treatment effects in randomized clinical trials (or similar studies like A/B-testing), exploiting data-adaptive predictions from prognostic baseline covariates, with little (or no) bias in finite samples even when predictions are biased. Empirical and methodological results demonstrate promise of automated covariate adjustment for improving statistical power of trial analyses.
format Preprint
id arxiv_https___arxiv_org_abs_2404_11150
institution arXiv
publishDate 2024
record_format arxiv
spellingShingle Automated, efficient and model-free inference for randomized clinical trials via data-driven covariate adjustment
Van Lancker, Kelly
Díaz, Iván
Vansteelandt, Stijn
Methodology
In 2023, the U.S. Food and Drug Administration issued guidance for adjustment of covariates in randomized clinical trials, emphasizing its role in enhancing precision and power through prognostic baseline variables. Despite its potential, many trials underutilize this method partly due to challenges in pre-specifying optimal baseline covariates and their functional forms. We explore the potential of automated, data-adaptive methods-including stepwise regression, Lasso and flexible machine learning algorithms-for covariate adjustment, addressing the challenge of pre-specification. Our approach ensures valid and interpretable treatment effect estimates and standard errors, even when outcome models are misspecified or biased outcome predictions are used. This differs from most competing methods, which assume correctly specified models for consistent standard errors. Our estimators require cross-fitting for reliable standard error estimation, though it can be omitted when variable selection is used, provided the outcome model satisfies an ultra-sparsity assumption. As such, we arrive at simple estimators and standard errors for marginal treatment effects in randomized clinical trials (or similar studies like A/B-testing), exploiting data-adaptive predictions from prognostic baseline covariates, with little (or no) bias in finite samples even when predictions are biased. Empirical and methodological results demonstrate promise of automated covariate adjustment for improving statistical power of trial analyses.
title Automated, efficient and model-free inference for randomized clinical trials via data-driven covariate adjustment
topic Methodology
url https://arxiv.org/abs/2404.11150